W 926 (ENALAPRIL 20 mg)
Pill imprint W 926 has been identified as Enalapril maleate 20 mg.
Enalapril is used in the treatment of high blood pressure; diabetic kidney disease; heart failure; left ventricular dysfunction; hypertensive emergency (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Enalapril 20 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for W 926 (ENALAPRIL 20 mg)
- 20 mg
- 8.00 mm
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Wockhardt USA
- National Drug Code (NDC):
- Inactive Ingredients:
- stearic acid
|NDC Code||Manufacturer / Repackager|
|00172-4198||Ivax Pharmaceuticals Inc|
|68084-0392||Amerisource Health Services|
|63304-0837||Ranbaxy Pharmaceuticals Inc.|
|63874-0987||Altura Pharmaceuticals Inc (repackager)|
|54569-5135||A S Medication Solutions LLC (repackager)|
|55887-0227||Diversified Healthcare Services Inc (repackager)|
|23490-5492||Palmetto State Pharmaceuticals Inc (repackager)|
|33358-0128||Core Pharmaceuticals Inc (repackager)|
|21695-0489||Rebel Distributors Corp (repackager)|
|66336-0393||Dispensing Solutions Inc. (repackager)|
Note: Inactive ingredients may vary.